RJF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RJF is not a strong buy right now for a Beginner investor focused on long-term holding, but it is a reasonable hold if already owned. The pre-market setup is constructive, yet the stock lacks a proprietary buy signal, analyst sentiment is mostly neutral-to-mixed, insider selling is notable, and the latest financial snapshot is unavailable. With no urgent upside catalyst and no clear deep-value signal, I would not call it a direct buy today for an impatient long-term beginner with $50,000-$100,000.
RJF is trading pre-market around 150.27-150.42, which is above the pivot support at 147.856 and below first resistance at 152.218. MACD histogram is positive and expanding, which supports short-term upside momentum. RSI_6 at 55.05 is neutral-to-mildly bullish, and moving averages are converging, suggesting a range-bound but improving trend rather than a strong breakout. Near-term trend data points to modest upside over the next day, but only slight weakness over the next week, so the technical picture is constructive but not decisive.
Momentum is improving technically with a positive, expanding MACD histogram. The stock is holding above pivot support. Analyst commentary includes some support for better investment banking revenue and net interest income expectations. The company is still viewed as having a strong balance sheet and solid pipelines according to some firms. No recent congress trading data is available, so there is no added political trading signal either way.
Analyst sentiment is mostly Hold/Neutral, and several firms have lowered price targets despite occasional small increases. TD Cowen called the latest update disappointing and remains watchful on liquidity, margins, and economics. Insider selling has increased sharply, up 448.35% over the last month, which is a meaningful negative. The financial snapshot for the latest quarter is unavailable here, so there is no confirmed fresh acceleration in fundamentals. The news provided is mainly political-macro and not a direct business catalyst for RJF.
Latest quarter season: fiscal Q2. Based on analyst notes around the fiscal Q2 report, Raymond James delivered a revenue-driven beat, but higher expenses were a drag on forecasts. Firms noted stronger recruiting and tech spend, while some see better investment banking revenue and net interest income in 2026-2027. Overall, the latest quarter appears solid but not fast-growing, with expense pressure offsetting some top-line strength.
Recent analyst action has been mixed but mostly cautious. TD Cowen cut the target to $155 and kept Hold. Morgan Stanley raised the target slightly to $172 and kept Equal Weight. BofA lowered the target to $172 and kept Neutral. UBS raised to $166 and kept Neutral. BMO lifted to $165 with Market Perform. Barclays remains the most bullish with Overweight and a $182 target, but the broader Wall Street view is still centered around Neutral/Hold, which means pros see fair value more than clear upside.
